Zero-dimensional carbon nanomaterials for central nervous system diseases
Clicks: 25
ID: 311816
2022
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
7.2
/100
25 views
11 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #402 of 631 articles by views in science and technology of advanced materials
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 631 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Zero-dimensional carbon nanomaterials present immense possibilities in the field of new diagnostic and therapeutic technologies to diagnose, treat, and monitor CNS diseases, as seem in the applications for Parkinson's disease, Alzheimer's disease, and stroke. Their ability to cross the BBB, antioxidant properties, inherent photoluminescence, ability to improve the effectiveness of medical therapies, and early and precise detection of pathophysiology markers of those diseases highlight this potential.
| Reference Key |
persistent_1771692870_6999e346b114d
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Tyciane de Souza Nascimento, Stephen Rathinaraj Benjamin, Albert Layo Costa de Assis, Jessica Rabelo Bezerra, Jessica Maria Pessoa Gomes, Geanne Matos de Andrade, Reinaldo Barreto Oriá |
| Journal | science and technology of advanced materials |
| Year | 2022 |
| DOI |
10.1088/978-0-7503-4048-9ch9
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.